Leslie Chavez-Galan
Overview
Explore the profile of Leslie Chavez-Galan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
950
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Buendia-Roldan I, Martinez-Espinosa K, Aguirre M, Aguilar-Duran H, Palma-Lopez A, Palacios Y, et al.
Immun Inflamm Dis
. 2024 Jul;
12(7):e1305.
PMID: 39031504
Background: Persistent respiratory symptoms and lung abnormalities post-COVID-19 are public health problems. This study evaluated biomarkers to stratify high-risk patients to the development or persistence of post-COVID-19 interstitial lung disease....
12.
Choreno-Parra J, Ramon-Luing L, Castillejos M, Ortega-Martinez E, Tapia-Garcia A, Matias-Martinez M, et al.
Front Microbiol
. 2024 Jun;
15:1392782.
PMID: 38881671
Introduction: The proteolytic activity of A Disintegrin and Metalloproteinase 17 (ADAM17) regulates the release of tumor necrosis factor (TNF) and TNF receptors (TNFRs) from cell surfaces. These molecules play important...
13.
Cevallos J, Lome-Maldonado C, Quintanilla-Martinez L, Montes-Mojarro I, Islas-Munoz B, Ramirez A, et al.
Rev Invest Clin
. 2024 May;
76(3):145-158.
PMID: 38781946
Background: The 5 edition of the World Health Organization Classification of Hematolymphoid Tumors recently defined immune deficiency/dysregulation (IDD)-associated-lymphoid-proliferations in HIV settings, where information is scarce, often gone under or misdiagnosed....
14.
Flores-Gonzalez J, Ramon-Luing L, Falfan-Valencia R, Batista C, Soto-Alvarez S, Huerta-Nunez L, et al.
Biochim Biophys Acta Mol Basis Dis
. 2024 May;
1870(6):167219.
PMID: 38734321
Chronic infections induce CD4+ T-cells with cytotoxic functions (CD4 CTLs); at present, it is still unknown whether latent tuberculosis (LTB) and active tuberculosis (ATB) induce CD4 CTLs. Plasma and cells...
15.
Gajate-Arenas M, Fricke-Galindo I, Garcia-Perez O, Dominguez-de-Barros A, Perez-Rubio G, Dorta-Guerra R, et al.
Int J Mol Sci
. 2024 May;
25(9).
PMID: 38731851
COVID-19 is characterized by a wide range of clinical manifestations, where aging, underlying diseases, and genetic background are related to worse outcomes. In the present study, the differential expression of...
16.
Lopez-Bielma M, Falfan-Valencia R, Fierro-Pina A, Abarca-Rojano E, Cordoba-Lanus E, Fricke-Galindo I, et al.
Heliyon
. 2024 Apr;
10(8):e29493.
PMID: 38628728
Introduction: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of Coronavirus Disease 2019 (COVID-19). The disease has a wide range of clinical manifestations, from asymptomatic to...
17.
Gutierrez-Perez I, Buendia-Roldan I, Zaragoza-Garcia O, Perez-Rubio G, Villafan-Bernal J, Chavez-Galan L, et al.
Heliyon
. 2024 Mar;
10(6):e27997.
PMID: 38524554
Background: Enzymes of the peptidylarginine deiminase family (PADs) play a relevant role in the pathogenesis of COVID-19. However, the association of single nucleotide polymorphisms (SNPs) in their genes with COVID-19...
18.
Flores-Gonzalez J, Chavez-Galan L, Falfan-Valencia R, Roldan I, Fricke-Galindo I, Veronica-Aguilar A, et al.
Int J Infect Dis
. 2023 Nov;
138:102-109.
PMID: 38029833
Objectives: We investigated the expression of toll-like receptor (TLR)-4 on the cell surface of innate and adaptive cells from patients with COVID-19 carrying the rs4986790 GG genotype in the TLR4...
19.
Flores-Gonzalez J, Urban-Solano A, Ramon-Luing L, Cancino-Diaz J, Contreras-Rodriguez A, Curiel-Quesada E, et al.
Front Immunol
. 2023 Nov;
14:1263458.
PMID: 38022616
Introduction: Tuberculosis (TB) is a bacterial infection caused by (). B cells are the central mediator of the humoral response; they are responsible for producing antibodies in addition to mediating...
20.
Ramon-Luing L, Flores-Gonzalez J, Angel Garcia-Rojas L, Islas-Munoz B, Volkow-Fernandez P, Chavez-Galan L
Clin Exp Immunol
. 2023 Oct;
215(2):190-201.
PMID: 37904542
Valganciclovir (VGC) was used in a randomized clinical trial in patients with disseminated Kaposi Sarcoma/human immunodeficiency virus (DKS/HIV) as add-on therapy to evaluate the proinflammatory axis tumor necrosis factor (TNF)...